| Literature DB >> 33977333 |
Thaís T T Tweed1, Carmen Woortman2, Stan Tummers2, Maikel J A M Bakens2, James van Bastelaar2, Jan H M B Stoot2.
Abstract
PURPOSE: Despite the enhanced recovery after surgery (ERAS) protocol, length of stay (LOS) after colorectal surgery varies considerably. The majority of longer admissions is often not medically necessary. We aimed to investigate possible reduction of LOS by perioperative education with an expected discharge date (EDD).Entities:
Keywords: Colorectal cancer; Enhanced recovery after surgery; Gastrointestinal; Perioperative education
Mesh:
Year: 2021 PMID: 33977333 PMCID: PMC8195902 DOI: 10.1007/s00384-021-03948-0
Source DB: PubMed Journal: Int J Colorectal Dis ISSN: 0179-1958 Impact factor: 2.571
Patient characteristics
| ERAS+ | n | ERAS | n | |||
|---|---|---|---|---|---|---|
| Sex | 0.003 | |||||
Male Female | 49.6% 50.4% | 120 122 | 61.9% 38.1% | 208 128 | ||
| Age | (Median, IQR) | 73.8 (64.5–79.4) | 242 | 71.2 (62.8–76.4) | 336 | 0.019 |
| (Mean, SD) | 71.8 (±10.6) | 70.1 (±10.2) | ||||
| UICC stage | 0.056 | |||||
| Stadium 0 | 2.5% | 6 | 3.3% | 11 | ||
| Stadium IA | 8.7% | 21 | 9.5% | 32 | ||
| Stadium IB | 21.1% | 51 | 14.0% | 47 | ||
| Stadium IIA | 35.1% | 85 | 35.7% | 120 | ||
| Stadium IIB | 19.8% | 48 | 18.8% | 63 | ||
| Stadium IIIA | 7.0% | 17 | 8.6% | 29 | ||
| Stadium IIIB | 2.1% | 5 | 2.1% | 7 | ||
| Stadium IV | 3.7% | 9 | 8.0% | 27 | ||
| CCI | 0.235 | |||||
| 0–3 | 11.6% | 28 | 8.9% | 30 | ||
| 4–6 | 55.8% | 135 | 52.1% | 175 | ||
| >7 | 32.6% | 79 | 39.0% | 131 | ||
| Procedure | 0.419 | |||||
| Open* | 13.6% | 33 | 16.1% | 54 | ||
| Laparoscopic | 86.4% | 209 | 83.9% | 282 |
Continues variables reported as mean; categorical variables reported as percentages. ERAS describes patients from the 2016 cohort, ERAS+ from the 2018 cohort
IQR interquartile range, SD Standard deviation, UICC the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours, CCI Charlson Comorbidity Index, Procedure performed surgical technique
p-value key: *Conversions included, 24 cases in both groups
Primary and secondary outcomes
| ERAS+ | n | ERAS | n | ||
|---|---|---|---|---|---|
| Median length of stay (median, IQR) | 4.0 (3.0–6.0) | 242 | 5.0 (4.0–8.0) | 336 | <0.001 |
| Mean length of stay | 5.4 (±4.58) | 242 | 7.2 (±6.90) | 336 | < 0.001 |
| Clavien Dindo | < 0.001 | ||||
| 0 | (70.7%) | 171 | (41.1%) | 138 | |
| 1–3a | (19.4%) | 47 | (47.6%) | 160 | |
| 3b-5 | (9.9%) | 24 | (11.3%) | 38 | |
| Reintervention*<90 days, | 0.571 | ||||
| Yes | (10.3%) | 25 | (8.9%) | 30 | |
| No | (89.7%) | 217 | (91.1%) | 306 | |
| Readmission*< 90 days | 0.807 | ||||
| Yes | (9.5%) | 23 | (10.1%) | 34 | |
| No | (90.5%) | 219 | (89.9%) | 302 | |
| Mortality | |||||
| < 30 days | (1.7%) | 4 | (0.8%) | 3 | 0.261 |
| 30 > days < 90 | (0.4%) | 1 | (1.7%) | 6 | |
| No | (97.9%) | 237 | (97.3%) | 327 |
Length of stay reported in days. *Including scheduled ileostomy reversal for rectum resections
Results of implementing EDD
| Expected day of discharge met? | ERAS+, |
|---|---|
| Yes | 144 (59.5%) |
| No | 95 (39.3%) |
| Medical cause | 64 (67.4%) |
| Waiting for care | 21 (22.1%) |
| Insecurity | 6 (6.3%) |
| Weekend | 4 (4.2%) |
| Deceased during admission | 3 (1.2%) |
Multivariate linear regression analysis of predictors for length of stay
| Variables | Coefficient (β) | 95% CI | |
|---|---|---|---|
| Univariate | |||
| Age | 0.029 | −0.031/0.065 | 0.479 |
| Procedure | 0.067 | −0.222/2.334 | 0.105 |
| ERAS+ protocol | −0.145 | −2.787/-0.787 | <0.001 |
| UICC stage | 0.150 | 0.248/0.816 | <0.001 |
| Sex | 0.089 | 0.096/2.098 | 0.032 |
| CDC | 0.512 | 1.707/2.525 | <0.001 |
| CCI | 0.090 | 0.026/0.483 | 0.029 |
| Multivariate | |||
| ERAS+ protocol | −0.123 | −2.420/−0.629 | 0.001 |
| UICC stage | 0.081 | 0.134/2.544 | 0.029 |
| Sex | 0.044 | −0.352/1.437 | 0.234 |
| CDC | 0.433 | 7.007/9.811 | <0.001 |
| CCI | 0.080 | 0.070/1.490 | 0.031 |
Procedure performed surgical technique, laparoscopic or open, ERAS variable used to distinguish the used protocol in the two study groups, UICC stage the Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours, CDC Clavien Dindo classification, CCI Charlson comorbidity index, CI confidence intervals